Zobrazeno 1 - 10
of 1 537
pro vyhledávání: '"Cappellen, D"'
Autor:
Amintas S; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France. samuel.amintas@u-bordeaux.fr.; Department of Tumor Biology and Tumor Library, CHU Bordeaux, Bordeaux, France. samuel.amintas@u-bordeaux.fr., Cullot G; Bordeaux Institute in Oncology - BRIC - MoTRIL team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Biology, ETH Zurich, Zurich, Switzerland., Boubaddi M; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Digestive Surgery, CHU Bordeaux, Bordeaux, France., Rébillard J; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France., Karembe L; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France., Turcq B; Bordeaux Institute in Oncology - BRIC - MoTRIL team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; CRISP'edit, TBMCore, CNRS UAR3427, INSERM US005, Bordeaux, France., Prouzet-Mauléon V; Bordeaux Institute in Oncology - BRIC - MoTRIL team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; CRISP'edit, TBMCore, CNRS UAR3427, INSERM US005, Bordeaux, France., Bedel A; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France., Moreau-Gaudry F; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France., Cappellen D; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Tumor Biology and Tumor Library, CHU Bordeaux, Bordeaux, France., Dabernat S; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France. sandrine.dabernat@u-bordeaux.fr.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France. sandrine.dabernat@u-bordeaux.fr.
Publikováno v:
Journal of biological engineering [J Biol Eng] 2024 Oct 01; Vol. 18 (1), pp. 53. Date of Electronic Publication: 2024 Oct 01.
Autor:
Guillard M; Service d'Anatomie et Cytologie Pathologiques, CHRU Brest, Brest, France., Caumont C; Service de Biologie des Tumeurs, CHU Bordeaux, Pessac, France.; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Université de Bordeaux, Pessac, France., Marcorelles P; Service d'Anatomie et Cytologie Pathologiques, CHRU Brest, Brest, France.; LBAI, UMR1227 INSERM, Université de Bretagne Occidentale, Brest, France., Merlio JP; Service de Biologie des Tumeurs, CHU Bordeaux, Pessac, France.; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Université de Bordeaux, Pessac, France., Cappellen D; Service de Biologie des Tumeurs, CHU Bordeaux, Pessac, France.; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Université de Bordeaux, Pessac, France., Uguen A; Service d'Anatomie et Cytologie Pathologiques, CHRU Brest, Brest, France arnaud.uguen@chu-brest.fr.; LBAI, UMR1227 INSERM, Université de Bretagne Occidentale, Brest, France.
Publikováno v:
Journal of clinical pathology [J Clin Pathol] 2024 Jul 18; Vol. 77 (8), pp. 561-567. Date of Electronic Publication: 2024 Jul 18.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Guillon J; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Le Borgne M; Small Molecules for Biological Targets Team, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, CNRS 5286, INSERM 1052, Université Claude Bernard Lyon 1, Univ. Lyon, F-69373 Lyon, France., Milano V; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Guédin-Beaurepaire A; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Moreau S; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Pinaud N; ISM-CNRS UMR 5255, Univ. Bordeaux, F-33405 Talence, France., Ronga L; E2S UPPA, CNRS, IPREM, Université de Pau et des Pays de l'Adour, F-64053 Pau, France., Savrimoutou S; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Albenque-Rubio S; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Marchivie M; ICMCB-UMR 5026, Univ. Bordeaux, F-33608 Pessac, France., Kalout H; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Walker C; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Chevallier L; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Buré C; CNRS, INSERM, IECB, US1, UAR 3033, Univ. Bordeaux, F-33600 Pessac, France., Largy E; CNRS, INSERM, ARNA, UMR 5320, U1212, IECB, Univ. Bordeaux, F-33600 Pessac, France., Gabelica V; CNRS, INSERM, ARNA, UMR 5320, U1212, IECB, Univ. Bordeaux, F-33600 Pessac, France., Mergny JL; Ecole Polytechnique, Laboratoire d'Optique et Biosciences, CNRS, INSERM, Institut Polytechnique de Paris, F-91120 Palaiseau, France., Baylot V; Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, CNRS UMR7258, Inserm U1068, Univ. Aix Marseille, F-13009 Marseille, France., Ferrer J; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France., Idrissi Y; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France., Chevret E; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France., Cappellen D; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France.; Service Tumor Biology and Tumor Bank Laboratory, Groupe Hospitalier Bordeaux, CHU Bordeaux, F-33000 Bordeaux, France., Desplat V; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France., Schelz Z; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary., Zupkó I; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Dec 25; Vol. 17 (1). Date of Electronic Publication: 2023 Dec 25.
Autor:
Poetsch, L., Bronnimann, C., Loiseau, H., Frénel, J., Siegfried, A., Seizeur, R., Gauchotte, G., Cappellen, D., Carpentier, C., Figarella‑Branger, Dominique, Eimer, S., Meyronet, D., Ducray, F., Network, POLA, Rigaud, V.
Publikováno v:
Journal of Neuro-Oncology
Journal of Neuro-Oncology, Springer Verlag, 2021, 151 (2), pp.279-286. ⟨10.1007/s11060-020-03662-x⟩
Journal of Neuro-Oncology, 2021, 151 (2), pp.279-286. ⟨10.1007/s11060-020-03662-x⟩
Journal of Neuro-Oncology, Springer Verlag, 2021, 151 (2), pp.279-286. ⟨10.1007/s11060-020-03662-x⟩
Journal of Neuro-Oncology, 2021, 151 (2), pp.279-286. ⟨10.1007/s11060-020-03662-x⟩
Approximately 10% of IDH-mutant gliomas harbour non-canonical IDH mutations (non-p.R132H IDH1 and IDH2 mutations). The aim of this study was to analyse the characteristics of non-canonical IDH-mutant gliomas. We retrospectively analysed the character
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292020243ba497152714628a06def65d
https://doi.org/10.1007/s11060-020-03662-x
https://doi.org/10.1007/s11060-020-03662-x
Autor:
Di Tommaso S; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France.; Oncoprot Platform, TBM-Core US 005, Bordeaux, France., Dourthe C; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France.; Oncoprot Platform, TBM-Core US 005, Bordeaux, France., Dupuy JW; Université Bordeaux, Proteomics Platform, Bordeaux, France., Dugot-Senant N; Histology Platform, TBM-Core US 005, Bordeaux, France., Cappellen D; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France.; Bordeaux University Hospital Center, Tumor Bank and Tumor Biology Laboratory, Pessac, France., Cazier H; Pathology Department, Henri Mondor AP-HP Hospital, Créteil, France., Paradis V; Pathology Department, Henri Mondor AP-HP Hospital, Créteil, France., Blanc JF; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France.; Department of Hepatology and Oncology, Bordeaux University Hospital, INSERM CIC 1401, Bordeaux, France., Le Bail B; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France.; Pathology Department, Bordeaux University Hospital, Bordeaux, France., Balabaud C; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France., Bioulac-Sage P; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France., Saltel F; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France.; Oncoprot Platform, TBM-Core US 005, Bordeaux, France., Raymond AA; Université Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), Bordeaux, France.; Oncoprot Platform, TBM-Core US 005, Bordeaux, France.
Publikováno v:
JHEP reports : innovation in hepatology [JHEP Rep] 2023 Sep 22; Vol. 6 (2), pp. 100913. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2024).
Autor:
Cullot G; Bordeaux Institute in Oncology-BRIC-MoTRIL Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; Department of Biology, ETH Zurich, Zurich, Switzerland., Amintas S; Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; Department of Tumor Biology and Tumor Library, CHU Bordeaux, Bordeaux, France., Karembé L; Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, University of Bordeaux, Bordeaux, France., Prouzet-Mauléon V; Bordeaux Institute in Oncology-BRIC-MoTRIL Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; CRISP'edit, TBMCore, CNRS UAR3427, INSERM US005, University of Bordeaux, Bordeaux, France., Rébillard J; Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, University of Bordeaux, Bordeaux, France., Boureau L; Laboratory of Hematology, CHU Bordeaux, Bordeaux, France., Cappellen D; Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; Department of Tumor Biology and Tumor Library, CHU Bordeaux, Bordeaux, France., Bedel A; Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France., Moreau-Gaudry F; Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France., Dulucq S; Bordeaux Institute in Oncology-BRIC-MoTRIL Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; Laboratory of Hematology, CHU Bordeaux, Bordeaux, France.; Fi-LMC Group, Léon Bérard Center, Lyon, France., Dabernat S; Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France., Turcq B; Bordeaux Institute in Oncology-BRIC-MoTRIL Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; CRISP'edit, TBMCore, CNRS UAR3427, INSERM US005, University of Bordeaux, Bordeaux, France.; Fi-LMC Group, Léon Bérard Center, Lyon, France.
Publikováno v:
The CRISPR journal [CRISPR J] 2023 Apr; Vol. 6 (2), pp. 140-151. Date of Electronic Publication: 2023 Mar 13.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ropio J; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France.; Institute of Biomedical Sciences of Abel Salazar, Porto University, 4050-313 Porto, Portugal.; Faculty of Veterinary Medicine, Lusófona University, 1749-024 Lisbon, Portugal., Prochazkova-Carlotti M; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France., Batista R; Institute for Research and Innovation in Health (I3S), Porto University, 4200-135 Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Cancer Biology Group, Porto University, 4200-465 Porto, Portugal.; Faculty of Medicine, Porto University, 4200-319 Porto, Portugal., Pestana A; Institute for Research and Innovation in Health (I3S), Porto University, 4200-135 Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Cancer Biology Group, Porto University, 4200-465 Porto, Portugal.; Faculty of Medicine, Porto University, 4200-319 Porto, Portugal., Chebly A; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France.; Medical Genetics Unit, Faculty of Medicine, Saint Joseph University, Beirut 1104 2020, Lebanon.; Higher Institute of Public Health, Saint Joseph University, Beirut 1104 2020, Lebanon., Ferrer J; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France., Idrissi Y; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France., Cappellen D; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France.; Tumor Bank and Tumor Biology Laboratory, Bordeaux University Hospital, 33075 Bordeaux, France., Durães C; Institute for Research and Innovation in Health (I3S), Porto University, 4200-135 Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Cancer Biology Group, Porto University, 4200-465 Porto, Portugal., Boaventura P; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Cancer Biology Group, Porto University, 4200-465 Porto, Portugal., Vinagre J; Institute for Research and Innovation in Health (I3S), Porto University, 4200-135 Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Cancer Biology Group, Porto University, 4200-465 Porto, Portugal., Azzi-Martin L; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France.; UFR des Sciences Médicales, Bordeaux University, 33076 Bordeaux, France., Poglio S; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France., Cabeçadas J; Dermatology Departement, Instituto Português de Oncologia de Lisboa (IPO-L), 1099-023 Lisbon, Portugal., Campos MA; Institute for Research and Innovation in Health (I3S), Porto University, 4200-135 Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Cancer Biology Group, Porto University, 4200-465 Porto, Portugal.; Faculty of Medicine, Porto University, 4200-319 Porto, Portugal.; Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E., Dermatology Departement, 4434-502 Vila Nova de Gaia, Portugal., Beylot-Barry M; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France.; Dermatology Department, Bordeaux University Hospital, 33075 Bordeaux, France., Sobrinho-Simões M; Institute for Research and Innovation in Health (I3S), Porto University, 4200-135 Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Cancer Biology Group, Porto University, 4200-465 Porto, Portugal.; Faculty of Medicine, Porto University, 4200-319 Porto, Portugal.; Department of Pathology, Faculty of Medicine, Porto University, 4200-319 Porto, Portugal., Merlio JP; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France.; Tumor Bank and Tumor Biology Laboratory, Bordeaux University Hospital, 33075 Bordeaux, France., Soares P; Institute for Research and Innovation in Health (I3S), Porto University, 4200-135 Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Cancer Biology Group, Porto University, 4200-465 Porto, Portugal.; Faculty of Medicine, Porto University, 4200-319 Porto, Portugal.; Department of Pathology, Faculty of Medicine, Porto University, 4200-319 Porto, Portugal., Chevret E; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, 33000 Bordeaux, France.
Publikováno v:
Genes [Genes (Basel)] 2023 Feb 08; Vol. 14 (2). Date of Electronic Publication: 2023 Feb 08.
Autor:
Behnke A; Charité-Universitätsmedizin Berlin, Institute of Pathology and Berlin Institute of Health, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Cayre A; Département de Pathologie, Centre Jean-Perrin, Clermont-Ferrand, France., De Maglio G; Azienda Sanitaria Universitaria Friuli Centrale, Pathology Department, Santa Maria della Misericordia Hospital, Udine, Italy., Giannini G; Department Molecular Medicine, Università di Roma La Sapienza, Rome, Italy., Habran L; Anatomopathology Department, CHU Liège, Liège, Belgium., Tarsitano M; Di Laboratorio, A.O.R.N. Cardarelli, Medical Genetics Laboratory, and Ospedale Antonio Cardarelli, U.O.C. di Genetica Medica, Naples, Italy., Chetta M; Di Laboratorio, A.O.R.N. Cardarelli, Medical Genetics Laboratory, and Ospedale Antonio Cardarelli, U.O.C. di Genetica Medica, Naples, Italy., Cappellen D; Service de Biologie des Tumeurs, Centre Hospitalier Universitaire de Bordeaux, Hôpital du Haut Lévêque, Pessac, France., Lespagnol A; CHU de Rennes, Laboratoire de Génétique Somatique des Cancers, Rennes, France., Le Naoures C; CHU de Rennes, Service d'Anatomie et Cytologie Pathologiques, Rennes, France., Massazza G; Dipartimento Medicina di Laboratorio Anatomia Patologica, ASST Papa Giovanni XXIII, Bergamo, BG, Italy., Destro A; Pathology Department, Humanitas Clinical and Research Center-IRCCS, Milan, Italy., Bonzheim I; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Rau A; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Battmann A; Institut für Pathologie und Zytodiagnostik am Krankenhaus Nordwest, Frankfurt, Germany., Kah B; Institut für Hämatopathologie Hamburg, Hamburg, Germany., Watkin E; CYPATH, Villeurbanne, France., Hummel M; Charité-Universitätsmedizin Berlin, Institute of Pathology and Berlin Institute of Health, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Publikováno v:
Pathology oncology research : POR [Pathol Oncol Res] 2023 Jan 31; Vol. 29, pp. 1610707. Date of Electronic Publication: 2023 Jan 31 (Print Publication: 2023).